The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Li, S., Couet, J., & Lisanti, M. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29182 · Cited by 777
Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers
Hayes, D. F., Bast, R. C., Desch, C. E., Fritsche, H., Kemeny, N. E., Jessup, J. M., Locker, G. Y., Macdonald, J. S., Mennel, R. G., Norton, L., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.20.1456 · Cited by 748
Regulation of Integrin Function by the Urokinase Receptor
Wei, Y., Lukashev, M., Simon, D. I., Bodary, S. C., Rosenberg, S., Doyle, M. V., & Chapman, H. A. (1996) · Science · doi:10.1126/science.273.5281.1551 · Cited by 727
Wary, K. K., Mariotti, A., Zurzolo, C., & Giancotti, F. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81604-9 · Cited by 718
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase.
Vassalli, J. D., Baccino, D., & Belin, D. (1985) · The Journal of cell biology · doi:10.1083/jcb.100.1.86 · Cited by 712
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
Bajou, K., Noël, A., Gerard, R. D., Masson, V., Brunner, N., Holst-Hansen, C., Skobe, M., Fusenig, N. E., Carmeliet, P., Collen, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-923 · Cited by 677
The serpin PAI-1 inhibits cell migration by blocking integrin αvβ3 binding to vitronectin
Stefansson, S., & Lawrence, D. A. (1996) · Nature · doi:10.1038/383441a0 · Cited by 674
Sato, Y., & Rifkin, D. B. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.3.1199 · Cited by 637
Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Danø, K., Appella, E., & Blasi, F. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08132.x · Cited by 603
Self-citationLook, M. P., van Putten, W. L. J., Duffy, M. J., Harbeck, N., Christensen, I. J., Thomssen, C., Kates, R., Spyratos, F., Ferno, M., Eppenberger-Castori, S., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.2.116 · Cited by 596
Moro, L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.22.6622 · Cited by 584
Identification of the urokinase receptor as an adhesion receptor for vitronectin.
Wei, Y., Waltz, D. A., Rao, N., Drummond, R. J., Rosenberg, S., & Chapman, H. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)31646-6 · Cited by 581
Ploug, M., Rønne, E., Behrendt, N., Jensen, A. L., Blasi, F., & Danø, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52382-6 · Cited by 574
Self-citationGhiso, J. A. A., Kovalski, K., & Ossowski, L. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.89 · Cited by 549
Ellis, V., Behrendt, N., & Danø, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98963-5 · Cited by 498
Herz, J., Clouthier, D. E., & Hammer, R. E. (1992) · Cell · doi:10.1016/0092-8674(92)90511-a · Cited by 497
Declerck, P. J., De Mol, M., Alessi, M. C., Baudner, S., Pâques, E. P., Preissner, K. T., Müller-Berghaus, G., & Collen, D. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37610-0 · Cited by 485
Appella, E., Robinson, E. A., Ullrich, S. J., Stoppelli, M. P., Corti, A., Cassani, G., & Blasi, F. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61211-6 · Cited by 475
Self-citationPyke, C., Kristensen, P. K., Ralfkiaer, E. M., Grøndahl-Hansen, J., Eriksen, J., Blasi, F., & Danø, K. (1991) · PubMed · Cited by 471
Self-citationEstreicher, A., Mühlhauser, J., Carpentier, J. L., Orci, L., & Vassalli, J. D. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.783 · Cited by 469
Nykjaer, A., Petersen, C. M., Møller, B., Jensen, P. H., Moestrup, S. K., Holtet, T. L., Etzerodt, M., Thøgersen, H. C., Munch, M., & Andreasen, P. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42072-8 · Cited by 459
Deng, G., Curriden, S. A., Wang, S., Rosenberg, S., & Loskutoff, D. J. (1996) · The Journal of cell biology · doi:10.1083/jcb.134.6.1563 · Cited by 448
Sato, Y., Tsuboi, R., Lyons, R., Moses, H., & Rifkin, D. B. (1990) · The Journal of cell biology · doi:10.1083/jcb.111.2.757 · Cited by 444
Stoppelli, M. P., Corti, A., Soffientini, A., Cassani, G., Blasi, F., & Assoian, R. K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.15.4939 · Cited by 443
Self-citationJanicke, F., Prechtl, A., Thomssen, C., Harbeck, N., Meisner, C., Untch, M., Sweep, C. G. J. F., Selbmann, H.-K., Graeff, H., & Schmitt, M. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.12.913 · Cited by 434
Gladson, C. L., & Cheresh, D. A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115516 · Cited by 417
Liu, D., Ghiso, J. A. A., Estrada, Y., & Ossowski, L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00072-7 · Cited by 392
A Role for Caveolin and the Urokinase Receptor in Integrin-mediated Adhesion and Signaling
Wei, Y., Yang, X., Liu, Q., Wilkins, J. A., & Chapman, H. A. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.6.1285 · Cited by 392
Schmitt, M., Harbeck, N., Thomssen, C., et al. (1997) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1657541 · Cited by 386
Ossowski, L., & Aguirre-Ghiso, J. A. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00140-x · Cited by 380
Prevention of metastasis by inhibition of the urokinase receptor.
Crowley, C. W., Cohen, R. L., Lucas, B. K., Liu, G., Shuman, M. A., & Levinson, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5021 · Cited by 374
Cubellis, M. V., Wun, T. C., & Blasi, F. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08213.x · Cited by 371
Self-citationResnati, M., Pallavicini, I., Wang, J. M., Oppenheim, J., Serhan, C. N., Romano, M., & Blasi, F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022652999 · Cited by 360
Self-citationCancer invasion and tissue remodeling: common themes in proteolytic matrix degradation
Johnsen, M., Lund, L. R., Rømer, J., Almholt, K., & Danø, K. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80044-6 · Cited by 356
Plasminogen Activation Initiated by Single-chain Urokinase-type Plasminogen Activator
Ellis, V, Scully, M. F., & Kakkar, V. V. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94159-1 · Cited by 332
Stephens, R. W., Pöllänen, J., Tapiovaara, H., Leung, K. C., Sim, P. S., Salonen, E. M., Rønne, E., Behrendt, N., Danø, K., & Vaheri, A. (1989) · The Journal of cell biology · doi:10.1083/jcb.108.5.1987 · Cited by 320
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
Nykjar, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2610 · Cited by 309
Resnati, M., Guttinger, M., Valcamonica, S., Sidenius, N., Blasi, F., & Fazioli, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00502.x · Cited by 299
Self-citationPöllänen, J., Saksela, O., Salonen, E., Andreasen, P., Nielsen, L., Danø, K., & Vaheri, A. (1987) · The Journal of cell biology · doi:10.1083/jcb.104.4.1085 · Cited by 292
Cancer invasion and tissue remodeling‐cooperation of protease systems and cell types
DANØ, K., RØMER, J., NIELSEN, B. S., BJØRN, S., PYKE, C., RYGAARD, J., & LUND, L. R. (1999) · APMIS · doi:10.1111/j.1699-0463.1999.tb01534.x · Cited by 291
Plasma Urokinase Receptor Levels in Patients With Colorectal Cancer: Relationship to Prognosis
Stephens, R. W. (1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.10.869 · Cited by 279
Bugge, T. H., Flick, M. J., Danton, M. J., Daugherty, C. C., Romer, J., Dano, K., Carmeliet, P., Collen, D., & Degen, J. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5899 · Cited by 276
Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors.
Ellis, V, Wun, T. C., Behrendt, N., Rønne, E., & Danø, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38757-5 · Cited by 266
Busso, N., Masur, S. K., Lazega, D., Waxman, S., & Ossowski, L. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.126.1.259 · Cited by 263
Høyer-Hansen, G., Rønne, E., Solberg, H., Behrendt, N., Ploug, M., Lund, L. R., Ellis, V, & Danø, K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37176-5 · Cited by 252
The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator.
Behrendt, N., Ploug, M., Patthy, L., Houen, G., Blasi, F., & Danø, K. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89526-x · Cited by 248
Self-citationPloug, M., & Ellis, V. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00674-1 · Cited by 246
uPA, uPAR, PAI-I: Key intersection of proteolytic, adhesive and chemotacfic highways?
Blasi, F. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01121-3 · Cited by 243
Self-citationUrokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice.
Min, H. Y., Doyle, L. V., Vitt, C. R., Zandonella, C., Stratton-Thomas, J. R., Shuman, M. A., & Rosenberg, S. (1996) · PubMed · Cited by 242
Naldini, L., Vigna, E., Bardelli, A., Follenzi, A., Galimi, F., & Comoglio, P. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.603 · Cited by 242
Fazioli, F. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7279 · Cited by 238
Structural requirements for the growth factor activity of the amino-terminal domain of urokinase.
Rabbani, S. A., Mazar, A. P., Bernier, S. M., Haq, M., Bolivar, I., Henkin, J., & Goltzman, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49691-9 · Cited by 234
Kjøller, L., Kanse, S. M., Kirkegaard, T., Rodenburg, K. W., Rønne, E., Goodman, S. L., Preissner, K. T., Ossowski, L., & Andreasen, P. A. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3540 · Cited by 233
Identification and characterization of genes associated with human hepatocellular carcinogenesis.
Kondoh, N., Wakatsuki, T., Ryo, A., Hada, A., Aihara, T., Horiuchi, S., Goseki, N., Matsubara, O., Takenaka, K., Shichita, M., et al. (1999) · PubMed · Cited by 229
Duffy, M. J. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.8.1194 · Cited by 229
Xue, W., Mizukami, I. F., Todd, R. F., & Petty, H. R. (1997) · PubMed · Cited by 221
Gutierrez, L. S., Schulman, A., Brito-Robinson, T., Noria, F., Ploplis, V. A., & Castellino, F. (2000) · PubMed · Cited by 217
Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy.
Waltz, D. A., & Chapman, H. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36688-7 · Cited by 210
Colman, R. W., Pixley, R. A., Najamunnisa, S., Yan, W., Wang, J., Mazar, A., & McCrae, K. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119669 · Cited by 208
Nguyen, D. H. D., Hussaini, I. M., & Gonias, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.14.8502 · Cited by 205
The urokinase-type plasminogen activator receptor, a GPI-linked protein, is localized in caveolae.
Stahl, A., & Mueller, B. M. (1995) · The Journal of cell biology · doi:10.1083/jcb.129.2.335 · Cited by 198
Czekay, R.-P., Kuemmel, T. A., Orlando, R. A., & Farquhar, M. G. (2001) · Molecular Biology of the Cell · doi:10.1091/mbc.12.5.1467 · Cited by 193
Sier, C. F. M., Stephens, R. W., Bízik, J., Mariani, A., Bassan, M., Pedersen, N. M., Frigerio, L., Ferrari, A. G., Danø, K., Brünner, N., et al. (1998) · PubMed · Cited by 191
Self-citationHarbeck, N., Kates, R. E., Look, M. P., Gelder, M. E. M., Klijn, J. G. M., Krüger, A., Kiechle, M. B., Jänicke, F., Schmitt, M., & Foekens, J. A. (2002) · PubMed · Cited by 191
Interaction of Plasminogen Activator Inhibitor (PAI-1) with Vitronectin
Salonen, E. M., Vaheri, A., Pöllänen, J., Stephens, R., Andreasen, P., Mayer, M., Danø, K., Gailit, J., & Ruoslahti, E. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83353-1 · Cited by 190
High-affinity urokinase receptor antagonists identified with bacteriophage peptide display.
Goodson, R. J., Doyle, M. V., Kaufman, S. E., & Rosenberg, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7129 · Cited by 190
Kjøller, L., & Hall, A. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.152.6.1145 · Cited by 188
Rønne, E., Behrendt, N., Ellis, V., Ploug, M., Danø, K., & Høyer-Hansen, G. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)81042-7 · Cited by 186
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
Cubellis, M. V., Andreasen, P., Ragno, P., Mayer, M., Danø, K., & Blasi, F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4828 · Cited by 180
Self-citationThe Jak/Stat Pathway and Urokinase Receptor Signaling in Human Aortic Vascular Smooth Muscle Cells
Dumler, I., Weis, A., Mayboroda, O. A., Maasch, C., Jerke, U., Haller, H., & Gulba, D. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.315 · Cited by 176
Odekon, L. E., Sato, Y., & Rifkin, D. B. (1992) · Journal of Cellular Physiology · doi:10.1002/jcp.1041500206 · Cited by 175
Targeting of Tumor Cells by Cell Surface Urokinase Plasminogen Activator-dependent Anthrax Toxin
Liu, S., Bugge, T. H., & Leppla, S. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011085200 · Cited by 168
Release of GPI‐anchored membrane proteins by a cell‐associated GPI‐specific phospholipase D.
Metz, C. N., Brunner, G., Choi-Muira, N. H., Nguyen, H., Gabrilove, J. L., Caras, I. W., ALTSZULER, N., Rifkin, D. B., Wilson, E. L., & Davitz, M. A. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06438.x · Cited by 163
Tang, H., Kerins, D. M., Hao, Q., Inagami, T., & Vaughan, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18268 · Cited by 159
ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients
Stephens, R. W., Pedersen, A. N., Nielsen, H. J., Hamers, M. J. A. G., Høyer‐Hansen, G., Rønne, E., Dybkjær, E., Danø, K., & Brünner, N. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.10.1868 · Cited by 157
Seiffert, D., & Loskutoff, D. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49921-8 · Cited by 154
Bugge, T. H., Lund, L. R., Kombrinck, K. K., Nielsen, B. S., Holmbäck, K., Drew, A. F., Flick, M. J., Witte, D. P., Danø, K., & Degen, J. L. (1998) · Oncogene · doi:10.1038/sj.onc.1201869 · Cited by 153
Expression and localization of urokinase-type plasminogen activator receptor in human gliomas.
Yamamoto, M., Sawaya, R. A., Mohanam, S., Rao, V. H., Bruner, J. M., Nicolson, G. L., & Rao, J. S. (1994) · PubMed · Cited by 149
Rømer, J., Lund, L. R., Eriksen, J., Pyke, C., Kristensen, P., & Danø, K. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12373187 · Cited by 143
A Urokinase Receptor-associated Protein with Specific Collagen Binding Properties
Behrendt, N., Jensen, O. N., Engelholm, L. H., Mørtz, E., Mann, M., & Danø, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1993 · Cited by 141
Nykjær, A., Christensen, E. I., Vorum, H., Hager, H., Petersen, C. M., Røigaard-Petersen, H., Min, H. Y., Vilhardt, F., Møller, L. B., Kornfeld, S. A., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.3.815 · Cited by 141
Høyer‐Hansen, G., Behrendt, N., Ploug, M., Danø, K., & Preissner, K. T. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01491-9 · Cited by 139
Urokinase-type plasminogen activator and its receptor: new targets for anti-metastatic therapy?
Fazioli, F., & Blasi, F. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90130-9 · Cited by 135
Self-citationThe Cleavage of the Urokinase Receptor Regulates Its Multiple Functions
Montuori, N., Carriero, M. V., Salzano, S., Rossi, G., & Ragno, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207494200 · Cited by 129
Carmeliet, P., Moons, L., Dewerchin, M. A., Rosenberg, S., Herbert, J., Lupu, F., & Collen, D. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.1.233 · Cited by 126
Ploug, M., Kjalke, M., Rønne, E., Weidle, U. H., Høyer‐Hansen, G., & Danø, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85366-8 · Cited by 125
Sidénius, N., Sier, C. F. M., & Blasi, F. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01624-0 · Cited by 122
Self-citationPedersen, N. M., Schmitt, M., Rønne, E., Nicoletti, M. I., Høyer‐Hansen, G., Conese, M., Giavazzi, R., Danø, K., Kuhn, W. C., & Jänicke, F. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116817 · Cited by 119
Moestrup, S. K., Holtet, T. L., Etzerodt, M., Thøgersen, H. C., Nykjær, A., Andreasen, P. A., Rasmussen, H. H., Sottrup‐Jensen, L., & Gliemann, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38702-2 · Cited by 117
Growth and Dissemination of Lewis Lung Carcinoma in Plasminogen-Deficient Mice
Bugge, T. H., Kombrinck, K. W., Xiao, Q., Holmbäck, K., Daugherty, C. C., Witte, D. P., & Degen, J. L. (1997) · Blood · doi:10.1182/blood.v90.11.4522 · Cited by 114
Chavakis, T., Kanse, S. M., Yutzy, B., LIJNEN, H. R., & Preissner, K. T. (1998) · Blood · doi:10.1182/blood.v91.7.2305 · Cited by 113
Taniguchi, T., Kakkar, A. K., Tuddenham, E. G. D., Williamson, R. C. N., & Lemoine, N. R. (1998) · PubMed · Cited by 112
Kjøller, L. (2002) · Biological Chemistry · doi:10.1515/bc.2002.002 · Cited by 112
Jensen, P. H., Christensen, E., Ebbesen, P., Gliemann, J., & Andreasen, P. A. (1990) · Cell Regulation · doi:10.1091/mbc.1.13.1043 · Cited by 111
Petro, G. D., Tavian, D., Copeta, A., Portolani, N., Giulini, S. M., & Barlati, S. (1998) · PubMed · Cited by 110
Heegaard, C. W., Simonsen, A. C. W., Oka, K., Kj, L., Christensen, A., Madsen, B. K., Ellgaard, L., Chan, L., & Andreasen, P. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20855 · Cited by 110
Koolwijk, P., Sidénius, N., Peters, E., Sier, C. F. M., Hanemaaijer, R., Blasi, F., & van Hinsbergh, V. W. M. (2001) · Blood · doi:10.1182/blood.v97.10.3123 · Cited by 109
Self-citationPlesner, T., Ralfkiaer, E. M., Wittrup, M., Johnsen, H. E., Pyke, C., Pedersen, T. L., Hansen, N. E., & Danø, K. (1994) · American Journal of Clinical Pathology · doi:10.1093/ajcp/102.6.835 · Cited by 104
Mustjoki, S. M., Sidénius, N., Sier, C. F. M., Blasi, F., Elonen, E., Alitalo, R., & Vaheri, A. I. (2000) · PubMed · Cited by 102
Self-citationKobayashi, H., Gotoh, J., Fujie, M., Shinohara, H., Moniwa, N., & Terao, T. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910570520 · Cited by 98
Degryse, B., Orlando, S., Resnati, M., Rabbani, S. A., & Blasi, F. (2001) · Oncogene · doi:10.1038/sj.onc.1204261 · Cited by 98
Self-citationUrokinase Regulates Vitronectin Binding by Controlling Urokinase Receptor Oligomerization
Sidénius, N., Andolfo, A., Fesce, R., & Blasi, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111736200 · Cited by 97
Self-citationvan der Pluijm, G., Sijmons, B., Vloedgraven, H. J., van der Bent, C., Drijfhout, J. W., Verheijen, J. A. N., Quax, P. H. A., Karperien, M., Papapoulos, S. E., & Löwik, C. W. G. M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61773-7 · Cited by 97
Vallera, D. A., Li, C., Jin, N., Panoskaltsis‐Mortari, A., & Hall, W. A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.8.597 · Cited by 95
Up-regulation of urokinase and urokinase receptor genes in malignant astrocytoma.
Gladson, C. L., Pijuan-Thompson, V., Olman, M. A., Gillespie, G. Y., & Yacoub, I. Z. (1995) · Europe PMC (PubMed Central) · Cited by 94
Sier, C. F. M., Sidénius, N., Mariani, A., Aletti, G. D., Agape, V., Ferrari, A. G., Casetta, G., Stephens, R. W., Brünner, N., & Blasi, F. (1999) · PubMed · Cited by 88
Self-citationThe role of vitronectin as multifunctional regulator in the hemostatic and immune systems
Preissner, K. T. (1989) · Annals of Hematology · doi:10.1007/bf00349063 · Cited by 87
Andolfo, A., English, W., Resnati, M., Murphy, G., Blasi, F., & Sidénius, N. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613202 · Cited by 80
Self-citationDomain 1 of the urokinase receptor (uPAR) is required for uPAR‐mediated cell binding to vitronectin
Sidénius, N., & Blasi, F. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01282-5 · Cited by 78
Self-citation6 The urokinase/urokinase-receptor system and cancer invasion
Conese, M., & Blasi, F. (1995) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(05)80273-2 · Cited by 75
Self-citationWahlberg, K., Høyer‐Hansen, G., & Casslén, B. G. (1998) · PubMed · Cited by 65
Schmitt, M., Magdolen, V., Sperl, S., Muehlenweg, B., & Harbeck, N. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.4.683 · Cited by 63
Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor
Høyer‐Hansen, G., Pessara, U., Holm, A., Pass, J., Weidle, U. H., Danø, K., & Behrendt, N. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580673 · Cited by 63
Chiaradonna, F., Fontana, L., Iavarone, C., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3013 · Cited by 61
Kobayashi, H., Sugino, D., She, M. Y., Ohi, H., Hirashima, Y., Shinohara, H., Fujie, M., Shibata, K., & Terao, T. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2530817.x · Cited by 60
Inhibitors of the Protease Domain of Urokinase-Type Plasminogen Activator
Rockway, T. W., Nienaber, V. L., & Giranda, V. L. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023392676 · Cited by 59
Lanza, Castoldi, Castagnar, Todd, Moretti, Spisani, Latorraca, Focarile, Roberti, & Traniello (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00932.x · Cited by 57
Ploug, M. (1998) · Biochemistry · doi:10.1021/bi981203r · Cited by 56
Møller, L. B., Ploug, M., & Blasi, F. (1992) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1992.tb17213.x · Cited by 56
Self-citationVitronectin binding to urokinase receptor in human breast cancer.
Carriero, M. V., Vecchio, S. D., Franco, P., et al. (1997) · PubMed · Cited by 54
Alitalo, R., Stephens, R., Vaheri, A., & Mustjoki, S. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614558 · Cited by 49
Higazi, A. A., Upson, R. H., Cohen, R., Manuppello, J. R., Bognacki, J. J., Henkin, J., McCrae, K., Kounnas, M., Strickland, D., Preissner, K., et al. (1996) · Blood · doi:10.1182/blood.v88.2.542.bloodjournal882542 · Cited by 47
Conforti, G., Domı́nguez-Jiménez, C., Rønne, E., Høyer‐Hansen, G., & Dejana, E. (1994) · Blood · doi:10.1182/blood.v83.4.994.994 · Cited by 47
Fernebro, E., Madsen, R. R., Fernö, M., Brünner, N., Bendahl, P., Christensen, I. J., Johnson, A. T., & Nilbert, M. C. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00422-6 · Cited by 45
Fabbrini, M. S., Carpani, D., Rivero, I. B., & Soria, M. R. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.13.9367352 · Cited by 42
Rajagopal, V., & Kreitman, R. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7566 · Cited by 41
Yamamoto, M., Sawaya, R. A., Mohanam, S., Rao, V. H., Bruner, J. M., Nicolson, G. L., Ohshima, K., & Rao, J. S. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01052889 · Cited by 39
Ippoliti, R., Lendaro, E., Benedetti, P. A., Torrisi, M. R., Belleudi, F., Carpani, D., Soria, M. R., & Fabbrini, M. S. (2000) · The FASEB Journal · doi:10.1096/fj.14.10.1335 · Cited by 37
Bajou, K., Lewalle, J., Martinez, C. R., Soria, C., Lu, H., Noël, A., & Foidart, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10487 · Cited by 35
Riisbro, R., Stephens, R. W., Brünner, N., Christensen, I. J., Nielsen, H. J., Heilmann, L., & von Tempelhoff, G.-F. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6324 · Cited by 34
Shetty, S., & Idell, S. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0789 · Cited by 33
Increased Levels of Urokinase Receptor in Plasma of Head and Neck Squamous Cell Carcinoma Patients
Schmidt, F. H. M. (1999) · Acta Oto-Laryngologica · doi:10.1080/00016489950180342 · Cited by 26
Bessler, M., Rosti, V., Peng, Y., Cattoretti, G., Notaro, R., Ohsako, S., Elkon, K. B., & Luzzatto, L. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200209)32:9<2607::aid-immu2607>3.0.co;2-h · Cited by 17
Soluble urokinase receptor from fibrosarcoma HT-1080 cells.
Lau, H. K. F., & Kim, M. (1994) · PubMed · Cited by 13
Cited by
Chang, H. Y., Sneddon, J. B., Alizadeh, A. A., Sood, R., West, R. B., Montgomery, K., Chi, J.-T., Rijn, M. V. D., Botstein, D., & Brown, P. O. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020007 · Cited by 951
Synovial fibroblasts: key players in rheumatoid arthritis
Huber, L. C., Distler, O., Tarner, I., Gay, R. E., Gay, S., & Pap, T. (2006) · Rheumatology · doi:10.1093/rheumatology/kel065 · Cited by 607
Weng, C.-J., & Yen, G.-C. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.03.001 · Cited by 485
Mahmood, N., Mihalcioiu, C., & Rabbani, S. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00024 · Cited by 478
Prieur, A., Tirode, F., Cohen, P., & Delattre, O. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7275-7283.2004 · Cited by 420
Metadata
- Authors
- Sidenius, N., & Blasi, F.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2003-06
- Volume
- 22
- Issue
- 2-3
- Pages
- 205-222
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W1555312557
- Cited by
- 368
- References
- 135
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.